The Times of Israel on MSN
Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
As 1 out of every 3 adults worldwide suffers from the condition, Hebrew University scientists use non-psychoactive substances ...
A new machine learning model built using a simple and interpretable approach predicts in-hospital death in patients with acute liver failure and reveals top risk drivers.
A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified ...
Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...
A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...
CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...
Researchers have discovered that non-psychoactive cannabis compounds, CBD and CBG, can significantly reduce liver fat and ...
New research from Masonic Medical Research Institute shows that fatty liver disease alone does not directly cause heart failure with preserved ejection fraction.
FDA grants orphan drug status to orziloben for intestinal failure-associated liver disease (90)Orziloben secures FDA orphan ...
In experiments on pigs, researchers found that some formula fats can strain the newborn liver far earlier than expected.
Sorbitol, a common sugar alcohol used in zero-calorie foods and found naturally in some fruits, isn’t just a passive ...
Uveal melanoma is a rare cancer with limited treatment options, and approximately 90% of patients who develop metastatic disease have liver involvement. In a small randomized trial, 55% of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results